Prabhudas Lilladher has recommended accumulating shares of Zydus Lifesciences, setting a target price of ₹1,305 in their research report dated August 12, ...

The stock market faced profit booking after hitting new highs, closing in the red on July 10. About 1,640 shares declined, while 694 shares advanced on the ...